RGNX - REGENXBIO Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.50
DETAILS
HIGH:
$45.00
LOW:
$12.00
MEDIAN:
$19.00
CONSENSUS:
$22.50
UPSIDE:
254.33%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 170.4 | 83.3 | 90.2 | 112.7 | 470.3 | 154.6 | 35.2 | 218.5 | 10.4 | 4.6 | 7.6 | 6.1 | 6.1 |
| Cost of Revenue | 20.3 | 33.6 | 37.2 | 54.5 | 51.8 | 35.7 | 8.2 | 9.6 | 1.7 | 1.0 | 1.5 | 1.0 | 0.3 |
| Gross Profit | 150.1 | 49.8 | 53.0 | 58.2 | 418.5 | 118.9 | 27.0 | 208.9 | 8.7 | 3.6 | 6.1 | 5.1 | 5.8 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 228.3 | 208.5 | 232.3 | 242.5 | 181.4 | 166.3 | 124.2 | 83.9 | 57.2 | 45.5 | 17.3 | 5.0 | 5.1 |
| SG&A Expenses | 82.9 | 76.6 | 88.5 | 85.3 | 79.3 | 63.8 | 51.8 | 36.9 | 27.2 | 23.6 | 11.9 | 3.9 | 5.5 |
| Other Expenses | 0.2 | (2.0) | 0.4 | (6.7) | (2.2) | 8.0 | (0.0) | 0.0 | 0.1 | (0.1) | (0.0) | (0.0) | 0 |
| Operating Expenses | 311.3 | 283.1 | 321.2 | 321.1 | 258.5 | 238.1 | 176.0 | 120.8 | 84.6 | 69.0 | 29.2 | 8.8 | 10.5 |
| Operating Income | |||||||||||||
| Operating Income | (161.2) | (233.3) | (268.1) | (262.9) | 160.0 | (119.2) | (149.0) | 88.1 | (75.9) | (65.3) | (23.1) | (3.7) | (4.8) |
| Interest Expense | 45.0 | 12.7 | 6.9 | 23.3 | 26.3 | 0.8 | 0 | 0 | 0 | 0 | 0.0 | 0.3 | 0.6 |
| Interest Income | 12.3 | 0.2 | 0.0 | 0.3 | 0.7 | 4.3 | 3.0 | 8.9 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | (145.6) | (198.2) | (239.5) | (244.2) | 169.5 | (96.8) | (90.3) | 92.1 | (73.2) | (64.8) | (22.7) | (3.7) | (4.8) |
| EBIT | (161.2) | (214.4) | (256.8) | (257.2) | 160.0 | (105.2) | (97.5) | 88.1 | (75.9) | (65.3) | (22.8) | (3.7) | (4.8) |
| Income Before Tax | (193.9) | (227.1) | (263.6) | (280.4) | 141.2 | (106.0) | (97.5) | 104.1 | (73.2) | (63.4) | (22.8) | (4.0) | (5.4) |
| Income Tax Expense | 0 | 0 | (0.2) | (0.1) | 13.4 | 5.2 | (2.8) | 4.2 | 0.7 | (0.4) | (0.1) | 0 | 0 |
| Net Income | (193.9) | (227.1) | (263.5) | (280.3) | 127.8 | (111.2) | (94.7) | 99.9 | (73.2) | (63.0) | (22.8) | (4.0) | (5.4) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -3.76 | -4.59 | -6.02 | -6.50 | 3.01 | -2.98 | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 | -0.30 | -2.04 |
| EPS (Diluted) | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 | -2.98 | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 | -0.30 | -2.04 |
| Shares Outstanding | 51.6 | 49.5 | 43.7 | 43.2 | 42.4 | 37.3 | 36.7 | 36.6 | 29.9 | 26.4 | 9.2 | 13.1 | 2.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 34.5 | 57.5 | 34.5 | 97.0 | 345.2 | 338.4 | 69.5 | 75.6 | 46.7 | 24.8 |
| Short-Term Investments | 195.6 | 177.2 | 240.7 | 267.7 | 112.2 | 137.3 | 226.7 | 244.2 | 114.1 | 64.7 |
| Net Receivables | 26.4 | 21.6 | 26.3 | 30.3 | 32.4 | 43.0 | 38.1 | 8.6 | 0.5 | 1.0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 10.5 | 0 | 5.7 | 5.3 | 1.8 |
| Other Current Assets | 24.8 | 12.7 | 18.9 | 7.1 | 10.2 | 2.0 | 4.2 | 3.8 | 1.4 | 1.0 |
| Total Current Assets | 281.3 | 278.0 | 335.0 | 416.0 | 518.8 | 531.2 | 345.0 | 337.9 | 168.0 | 93.4 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 152.0 | 171.3 | 192.6 | 206.8 | 192.5 | 120.3 | 39.1 | 28.7 | 14.0 | 9.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 15.1 | 10.2 | 38.9 | 200.6 | 391.9 | 46.8 | 103.8 | 150.8 | 15.6 | 69.4 |
| Other Non-Current Assets | 4.6 | 6.5 | 7.5 | 9.9 | 10.7 | 9.9 | 10.0 | 26.4 | 1.1 | 0.6 |
| Total Non-Current Assets | 171.8 | 188.0 | 239.0 | 417.3 | 595.1 | 177.0 | 152.9 | 205.9 | 30.7 | 79.4 |
| Total Assets | 453.0 | 466.0 | 574.0 | 833.3 | 1,113.9 | 708.2 | 497.9 | 543.8 | 198.7 | 172.7 |
| Current Liabilities | ||||||||||
| Account Payables | 21.4 | 22.8 | 22.8 | 27.2 | 11.4 | 10.6 | 6.4 | 4.4 | 4.8 | 1.5 |
| Short-Term Debt | 47.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 10.5 | 0.1 | 0.1 | 1.8 | 3.3 | 0.4 | 0 | 0.6 | 0 | 0 |
| Other Current Liabilities | 38.4 | 51.9 | 86.0 | 66.7 | 57.7 | 51.6 | 10.9 | 7.0 | 3.8 | 4.8 |
| Total Current Liabilities | 118.1 | 103.2 | 130.3 | 130.4 | 130.5 | 81.4 | 33.7 | 22.2 | 14.4 | 9.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 147.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1 | 0 | 0 |
| Other Non-Current Liabilities | 0.6 | 29.0 | 49.7 | 97.8 | 134.2 | 175.0 | 1.8 | 3.6 | 1.2 | 1.3 |
| Total Non-Current Liabilities | 232.2 | 103.1 | 132.0 | 186.6 | 219.1 | 249.0 | 14.0 | 12.8 | 1.2 | 1.3 |
| Total Liabilities | 350.3 | 206.3 | 262.2 | 317.1 | 349.6 | 330.4 | 47.7 | 35.0 | 15.6 | 11.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,126.0) | (932.1) | (705.0) | (441.6) | (161.2) | (289.1) | (177.8) | (83.0) | (187.8) | (114.6) |
| Accumulated Other Comprehensive Income | (0.7) | (0.7) | (4.4) | (15.4) | (2.6) | (0.4) | 0.2 | (0.7) | (0.7) | (0.0) |
| Total Stockholders' Equity | 102.7 | 259.7 | 311.7 | 516.2 | 764.3 | 377.8 | 450.2 | 508.8 | 183.0 | 161.7 |
| Total Liabilities & Equity | 453.0 | 466.0 | 574.0 | 833.3 | 1,113.9 | 708.2 | 497.9 | 543.8 | 198.7 | 172.7 |
| Debt Metrics | ||||||||||
| Total Debt | 260.5 | 82.0 | 89.3 | 94.8 | 86.7 | 72.7 | 11.3 | 5.9 | 0 | 0 |
| Net Debt | 226.1 | 24.5 | 54.8 | (2.2) | (258.5) | (265.8) | (58.2) | (69.7) | (46.7) | (24.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (193.9) | (227.1) | (263.5) | (280.3) | 127.8 | (111.2) | (94.7) | 99.9 | (73.2) | (63.0) |
| Depreciation & Amortization | 15.6 | 16.2 | 17.3 | 12.9 | 9.6 | 8.4 | 7.2 | 4.0 | 2.7 | 0.5 |
| Stock-Based Compensation | 34.6 | 38.5 | 40.3 | 40.8 | 38.8 | 31.9 | 26.9 | 16.6 | 10.6 | 7.0 |
| Change in Working Capital | 11.8 | 5.5 | (10.9) | 14.0 | 40.2 | 14.2 | (5.3) | (7.8) | 0.9 | 5.2 |
| Other Non-Cash Items | 8.0 | (6.2) | (1.6) | 5.2 | 4.4 | (1.2) | (2.7) | (8.9) | (0.3) | (0.4) |
| Operating Cash Flow | (124.0) | (173.1) | (218.4) | (207.5) | 218.9 | (54.1) | (107.7) | 104.6 | (58.0) | (48.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (2.4) | (2.4) | (10.0) | (30.7) | (84.2) | (26.9) | (11.7) | (13.3) | (7.2) | (8.1) |
| Acquisitions | 0 | 0 | 0 | 0 | (5.0) | (149.6) | (296.0) | (179.7) | (0.5) | 0 |
| Purchases of Investments | (332.6) | (190.1) | (86.6) | (184.9) | (498.1) | (123.0) | (190.7) | (445.8) | (68.6) | (45.1) |
| Sales/Maturities of Investments | 319.1 | 290.2 | 287.5 | 203.7 | 175.7 | 272.7 | 296.0 | 179.7 | 71.0 | 72.6 |
| Other Investing Activities | 0.1 | 5.8 | 0 | 0 | 5.0 | 149.6 | 296.0 | 179.7 | 0.5 | (0.2) |
| Investing Cash Flow | (15.9) | 103.4 | 190.9 | (11.9) | (406.6) | 122.8 | 93.6 | (279.4) | (4.8) | 19.2 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 115.8 | (39.6) | (41.7) | (30.6) | (23.0) | 198.4 | 7.1 | 13.9 | 2.0 | 0.1 |
| Financing Cash Flow | 116.8 | 92.7 | (35.0) | (28.8) | 195.2 | 200.2 | 8.4 | 204.4 | 84.6 | 0.1 |
| Cash Position | ||||||||||
| Net Change in Cash | (23.1) | 23.0 | (62.4) | (248.3) | 7.5 | 268.9 | (5.8) | 29.7 | 21.8 | (29.3) |
| Cash at Beginning | 59.6 | 36.6 | 99.0 | 347.2 | 339.8 | 70.8 | 76.6 | 46.9 | 24.8 | 54.1 |
| Cash at End | 36.5 | 59.6 | 36.6 | 99.0 | 347.2 | 339.8 | 70.8 | 76.6 | 46.7 | 24.8 |
| Free Cash Flow | (126.4) | (175.6) | (228.4) | (238.2) | 134.7 | (80.9) | (119.4) | 91.4 | (65.2) | (56.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 170.4 | 83.3 | 90.2 | 112.7 | 470.3 | 154.6 | 35.2 | 218.5 | 10.4 | 4.6 | 7.6 | 6.1 | 6.1 |
| Gross Profit | 150.1 | 49.8 | 53.0 | 58.2 | 418.5 | 118.9 | 27.0 | 208.9 | 8.7 | 3.6 | 6.1 | 5.1 | 5.8 |
| Operating Income | (161.2) | (233.3) | (268.1) | (262.9) | 160.0 | (119.2) | (149.0) | 88.1 | (75.9) | (65.3) | (23.1) | (3.7) | (4.8) |
| Net Income | (193.9) | (227.1) | (263.5) | (280.3) | 127.8 | (111.2) | (94.7) | 99.9 | (73.2) | (63.0) | (22.8) | (4.0) | (5.4) |
| EPS (Diluted) | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 | -2.98 | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 | -0.30 | -2.04 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 34.5 | 57.5 | 34.5 | 97.0 | 345.2 | 338.4 | 69.5 | 75.6 | 46.7 | 24.8 | |||
| Total Assets | 453.0 | 466.0 | 574.0 | 833.3 | 1,113.9 | 708.2 | 497.9 | 543.8 | 198.7 | 172.7 | |||
| Total Debt | 260.5 | 82.0 | 89.3 | 94.8 | 86.7 | 72.7 | 11.3 | 5.9 | 0 | 0 | |||
| Stockholders' Equity | 102.7 | 259.7 | 311.7 | 516.2 | 764.3 | 377.8 | 450.2 | 508.8 | 183.0 | 161.7 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (124.0) | (173.1) | (218.4) | (207.5) | 218.9 | (54.1) | (107.7) | 104.6 | (58.0) | (48.6) | |||
| Capital Expenditure | (2.4) | (2.4) | (10.0) | (30.7) | (84.2) | (26.9) | (11.7) | (13.3) | (7.2) | (8.1) | |||
| Free Cash Flow | (126.4) | (175.6) | (228.4) | (238.2) | 134.7 | (80.9) | (119.4) | 91.4 | (65.2) | (56.7) | |||